The Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
PLoS One. 2012;7(12):e51812. doi: 10.1371/journal.pone.0051812. Epub 2012 Dec 14.
Post-myocardial infarction (MI) structural remodeling is characterized by left ventricular dilatation, fibrosis, and hypertrophy of the non-infarcted myocardium.
The goal of our study was to quantify post-MI electrical remodeling by measuring the sum absolute QRST integral (SAI QRST). We hypothesized that adverse electrical remodeling predicts outcomes in MADIT II study participants.
Baseline orthogonal ECGs of 750 MADIT II study participants (448 [59.7%] ICD arm) were analyzed. SAI QRST was measured as the arithmetic sum of absolute QRST integrals over all three orthogonal ECG leads. The primary endpoint was defined as sudden cardiac death (SCD) or sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) with appropriate ICD therapies. All-cause mortality served as a secondary endpoint.
Adverse electrical remodeling in post-MI patients was characterized by wide QRS, increased magnitudes of spatial QRS and T vectors, J-point deviation, and QTc prolongation. In multivariable Cox regression analysis after adjustment for age, QRS duration, atrial fibrillation, New York Heart Association heart failure class and blood urea nitrogen, SAI QRST predicted SCD/VT/VF (HR 1.33 per 100 mVms (95%CI 1.11-1.59); P = 0.002), and all-cause death (HR 1.27 per 100 mVms (95%CI 1.03-1.55), P = 0.022) in both arms. No interaction with therapy arm and bundle branch block (BBB) status was found.
In MADIT II patients, increased SAI QRST is associated with increased risk of sustained VT/VF with appropriate ICD therapies and all-cause death in both ICD and in conventional medical therapy arms, and in patients with and without BBB. Further studies of SAI QRST are warranted.
心肌梗死后(MI)的结构重构表现为左心室扩张、非梗死心肌纤维化和肥厚。
我们的研究目的是通过测量总和绝对 QRST 积分(SAI QRST)来量化 MI 后的电重构。我们假设不良的电重构可预测 MADIT II 研究参与者的结果。
分析了 750 名 MADIT II 研究参与者(448 名[59.7%] ICD 组)的基线正交心电图。SAI QRST 被测量为所有三个正交 ECG 导联上绝对 QRST 积分的算术和。主要终点定义为心脏性猝死(SCD)或伴有适当 ICD 治疗的持续性室性心动过速(VT)/心室颤动(VF)。全因死亡率作为次要终点。
MI 后患者的不良电重构表现为宽 QRS、空间 QRS 和 T 向量幅度增加、J 点偏移和 QTc 延长。在多变量 Cox 回归分析中,在调整年龄、QRS 持续时间、心房颤动、纽约心脏协会心力衰竭分级和血尿素氮后,SAI QRST 预测 SCD/VT/VF(每增加 100 mVms 的 HR 为 1.33(95%CI 1.11-1.59);P = 0.002)和全因死亡(每增加 100 mVms 的 HR 为 1.27(95%CI 1.03-1.55),P = 0.022),在 ICD 和常规药物治疗组中均如此。未发现与治疗组和束支传导阻滞(BBB)状态的交互作用。
在 MADIT II 患者中,SAI QRST 的增加与适当 ICD 治疗后持续性 VT/VF 和 ICD 与常规药物治疗组中全因死亡的风险增加相关,且与 BBB 有无无关。需要进一步研究 SAI QRST。